Related references
Note: Only part of the references are listed.Molecular intrinsic versus clinical subtyping in breast cancer: A comprehensive review
Agata Szymiczek et al.
CLINICAL GENETICS (2021)
25-Hydroxyvitamin D at time of breast cancer diagnosis and breast cancer survival
Charlotte Kanstrup et al.
BREAST CANCER RESEARCH AND TREATMENT (2020)
Vitamin D supplementation and total cancer incidence and mortality: a meta-analysis of randomized controlled trials
N. Keum et al.
ANNALS OF ONCOLOGY (2019)
Breast Cancer Treatment A Review
Adrienne G. Waks et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
Low pretreatment serum concentration of vitamin D at breast cancer diagnosis in postmenopausal women
Murilo Renato Matos Machado et al.
MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY (2019)
Characteristics and prognosis of stage I-III breast cancer subtypes in Brazil: The AMAZONA retrospective cohort study
Sergio Daniel Simon et al.
BREAST (2019)
Skeletal and Extraskeletal Actions of Vitamin D: Current Evidence and Outstanding Questions
Roger Bouillon et al.
ENDOCRINE REVIEWS (2019)
Vitamin D receptor expression in invasive breast tumors and breast cancer survival
Linnea Huss et al.
BREAST CANCER RESEARCH (2019)
Vitamin D and breast cancer: Past and present
JoEllen Welsh
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Vitamin D3 signaling and breast cancer: Insights from transgenic mouse models
Lei Sheng et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2018)
Breast cancer risk markedly lower with serum 25-hydroxyvitamin D concentrations >= 60 vs < 20 ng/ml (150 vs 50 nmol/L): Pooled analysis of two randomized trials and a prospective cohort
Sharon L. McDonnell et al.
PLOS ONE (2018)
The predictive value of Ki-67 before neoadjuvant chemotherapy for breast cancer: a systematic review and meta-analysis
Xianyu Chen et al.
FUTURE ONCOLOGY (2017)
Vitamin D deficiency is associated with poor breast cancer prognostic features in postmenopausal women
Benedito de Sousa Almeida-Filho et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2017)
Association of Serum Level of Vitamin D at Diagnosis With Breast Cancer Survival A Case-Cohort Analysis in the Pathways Study
Song Yao et al.
JAMA ONCOLOGY (2017)
A meta-analysis of biomarkers for the prognosis of triple-negative breast cancer patients
Yu Gui et al.
BIOMARKERS IN MEDICINE (2016)
Vitamin D intake, blood 25(OH)D levels, and breast cancer risk or mortality: a meta-analysis
Y. Kim et al.
BRITISH JOURNAL OF CANCER (2014)
Serum 25-hydroxyvitamin D levels and survival in colorectal and breast cancer patients: Systematic review and meta-analysis of prospective cohort studies
Haifa Maalmi et al.
EUROPEAN JOURNAL OF CANCER (2014)
Circulating 25-hydroxyvitamin D and postmenopausal breast cancer survival: Influence of tumor characteristics and lifestyle factors?
Alina Vrieling et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
The role of vitamin D in reducing cancer risk and progression
David Feldman et al.
NATURE REVIEWS CANCER (2014)
Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013
A. Goldhirsch et al.
ANNALS OF ONCOLOGY (2013)
Ki-67 is a prognostic parameter in breast cancer patients: results of a large population-based cohort of a cancer registry
E. C. Inwald et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Associations of serum 25-hydroxyvitamin D with overall and breast cancer-specific mortality in a multiethnic cohort of breast cancer survivors
Adriana Villasenor et al.
CANCER CAUSES & CONTROL (2013)
The Association Between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels
Luke J. Peppone et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Serum levels of 25-hydroxyvitamin D and survival in Norwegian patients with cancer of breast, colon, lung, and lymphoma: a population-based study
Steinar Tretli et al.
CANCER CAUSES & CONTROL (2012)
Vitamin D status at breast cancer diagnosis: correlation with tumor characteristics, disease outcome, and genetic determinants of vitamin D insufficiency
Sigrid Hatse et al.
CARCINOGENESIS (2012)
The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer
Aruna V. Krishnan et al.
STEROIDS (2012)
Does the evidence for an inverse relationship between serum vitamin D status and breast cancer risk satisfy the Hill criteria?
Sharif B. Mohr et al.
DERMATO-ENDOCRINOLOGY (2012)
Variants in the vitamin D pathway, serum levels of vitamin D, and estrogen receptor negative breast cancer among African-American women: a case-control study
Song Yao et al.
BREAST CANCER RESEARCH (2012)
Serum 25-hydroxyvitamin D and postmenopausal breast cancer survival: a prospective patient cohort study
Alina Vrieling et al.
BREAST CANCER RESEARCH (2011)
Alterations in Vitamin D signalling and metabolic pathways in breast cancer progression: a study of VDR, CYP27B1 and CYP24A1 expression in benign and malignant breast lesions
Nair Lopes et al.
BMC CANCER (2010)
Proliferation markers and survival in early breast cancer: A systematic review and meta-analysis of 85 studies in 32,825 patients
R. Stuart-Harris et al.
BREAST (2008)
Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes
Heike A. Bischoff-Ferrari et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2006)
The E-cadherin/catenin complex: an important gatekeeper in breast cancer tumorigenesis and malignant progression
G Berx et al.
BREAST CANCER RESEARCH (2001)
Share Paper
